Cargando…

Quantitative background parenchymal enhancement to predict recurrence after neoadjuvant chemotherapy for breast cancer

Breast background parenchymal enhancement (BPE) is an increasingly studied MRI parameter that reflects the microvasculature of normal breast tissue, which has been shown to change during neoadjuvant chemotherapy (NAC) for breast cancer. We aimed at evaluating the BPE in patients undergoing NAC and i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moliere, Sebastien, Oddou, Isabelle, Noblet, Vincent, Veillon, Francis, Mathelin, Carole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6914793/ https://www.ncbi.nlm.nih.gov/pubmed/31844135 http://dx.doi.org/10.1038/s41598-019-55820-5

Ejemplares similares

Background Parenchymal Enhancement on Preoperative Magnetic Resonance Imaging: Association With Recurrence-Free Survival in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
por: Choi, Ji Soo, et al.
Publicado: (2016)

Association Between Background Parenchymal Enhancement and Pathologic Complete Remission Throughout the Neoadjuvant Chemotherapy in Breast Cancer Patients
por: You, Chao, et al.
Publicado: (2017)

Background parenchymal enhancement: behavior during neoadjuvant chemotherapy for breast cancer and relationship with a pathological complete response
por: Teixeira, Sandra Regina Campos, et al.
Publicado: (2020)

Background Parenchymal Enhancement of the Contralateral Normal Breast: Association with Tumor Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy()
por: Chen, Jeon Hor, et al.
Publicado: (2015)

Changes in background parenchymal enhancement in HER2-positive breast cancer before and after neoadjuvant chemotherapy: Association with pathologic complete response
por: Dong, Jing-Min, et al.
Publicado: (2018)

Background parenchymal enhancement in preoperative breast MRI
por: Kohara, Satoko, et al.
Publicado: (2015)

Comparison of Segmentation Methods in Assessing Background Parenchymal Enhancement as a Biomarker for Response to Neoadjuvant Therapy
por: Nguyen, Alex Anh-Tu, et al.
Publicado: (2020)

MRI Texture Analysis of Background Parenchymal Enhancement of the Breast
por: Amano, Yasuo, et al.
Publicado: (2017)

MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer
por: Bennani-Baiti, Barbara, et al.
Publicado: (2016)

Response Predictivity to Neoadjuvant Therapies in Breast Cancer: A Qualitative Analysis of Background Parenchymal Enhancement in DCE-MRI
por: La Forgia, Daniele, et al.
Publicado: (2021)

Analysis of background parenchymal echogenicity on breast ultrasound: Correlation with mammographic breast density and background parenchymal enhancement on magnetic resonance imaging
por: Ko, Kyung Hee, et al.
Publicado: (2017)

Quantitative background parenchymal enhancement and fibro-glandular density at breast MRI: Association with BRCA status
por: Goodburn, Rosie, et al.
Publicado: (2023)

Quantitative assessment of background parenchymal enhancement in breast magnetic resonance images predicts the risk of breast cancer
por: Hu, Xiaoxin, et al.
Publicado: (2016)

Correction: MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer
por: Bennani-Baiti, Barbara, et al.
Publicado: (2016)

Correction: Quantitative background parenchymal enhancement and fibro-glandular density at breast MRI: Association with BRCA status
por: Goodburn, Rosie, et al.
Publicado: (2023)

Pretherapeutic Imaging for Axillary Staging in Breast Cancer: A Systematic Review and Meta-Analysis of Ultrasound, MRI and FDG PET
por: Le Boulc’h, Morwenn, et al.
Publicado: (2021)

MRI background parenchymal enhancement, breast density and serum hormones in postmenopausal women
por: Brooks, Jennifer D., et al.
Publicado: (2018)

Medical treatment of mammary desmoid-type fibromatosis: which benefit?
por: Scheer, Louise, et al.
Publicado: (2017)

Fibroglandular Tissue and Background Parenchymal Enhancement on Breast MR Imaging Correlates With Breast Cancer
por: Hu, Xiaoxin, et al.
Publicado: (2021)

Relevance of breast MRI in determining the size and focality of invasive breast cancer treated by mastectomy: a prospective study
por: Carin, Anne-julie, et al.
Publicado: (2017)

Quantitative evaluation of Kaiser score in diagnosing breast dynamic contrast-enhanced magnetic resonance imaging for patients with high-grade background parenchymal enhancement
por: Wang, Hui, et al.
Publicado: (2023)

Association of breast cancer with MRI background parenchymal enhancement: the IMAGINE case-control study
por: Watt, Gordon P., et al.
Publicado: (2020)

Harmonization of Quantitative Parenchymal Enhancement in T(1)‐Weighted Breast MRI
por: van der Velden, Bas H.M., et al.
Publicado: (2020)

Breast cancer and background parenchymal enhancement at breast magnetic resonance imaging: a meta-analysis
por: Hu, Na, et al.
Publicado: (2021)

Quantitative background parenchymal uptake on molecular breast imaging and breast cancer risk: a case-control study
por: Hruska, Carrie B., et al.
Publicado: (2018)

Post-Processing Bias Field Inhomogeneity Correction for Assessing Background Parenchymal Enhancement on Breast MRI as a Quantitative Marker of Treatment Response
por: Nguyen, Alex Anh-Tu, et al.
Publicado: (2022)

The association between breast cancer risk factors and background parenchymal enhancement at dynamic contrast-enhanced breast MRI
por: Hellgren, Roxanna, et al.
Publicado: (2020)

Prediction of background parenchymal enhancement on breast MRI using mammography, ultrasonography, and diffusion-weighted imaging
por: Kawamura, Akiko, et al.
Publicado: (2015)

Prophylactic breast irradiation reduces background parenchymal enhancement (BPE) on MRI: A secondary analysis()
por: Ben-David, Merav A., et al.
Publicado: (2019)

Ultrafast Dynamic Contrast-Enhanced Breast MRI: Lesion Conspicuity and Size Assessment according to Background Parenchymal Enhancement
por: Kim, Soo-Yeon, et al.
Publicado: (2020)

Fully automatic classification of breast MRI background parenchymal enhancement using a transfer learning approach
por: Borkowski, Karol, et al.
Publicado: (2020)

Generalizable attention U-Net for segmentation of fibroglandular tissue and background parenchymal enhancement in breast DCE-MRI
por: Nowakowska, Sylwia, et al.
Publicado: (2023)

Background parenchymal enhancement in contrast-enhanced MR imaging suggests systemic effects of intrauterine contraceptive devices
por: Huck, Luisa Charlotte, et al.
Publicado: (2022)

STARD3: A New Biomarker in HER2-Positive Breast Cancer
por: Lodi, Massimo, et al.
Publicado: (2023)

The correlation of background parenchymal enhancement in the contralateral breast with patient and tumor characteristics of MRI-screen detected breast cancers
por: Vreemann, Suzan, et al.
Publicado: (2018)

Background Parenchymal Enhancement on Breast MRI as a Prognostic Surrogate: Correlation With Breast Cancer Oncotype Dx Score
por: Zhang, Michelle, et al.
Publicado: (2021)

The Assessment of Background Parenchymal Enhancement (BPE) in a High-Risk Population: What Causes BPE?
por: You, Chao, et al.
Publicado: (2018)

Association between MRI background parenchymal enhancement and lymphovascular invasion and estrogen receptor status in invasive breast cancer
por: Li, Jun, et al.
Publicado: (2019)

Background Parenchymal Enhancement on Contrast-Enhanced Spectral Mammography: Influence of Age, Breast Density, Menstruation Status, and Menstrual Cycle Timing
por: Zhao, Shuang, et al.
Publicado: (2020)

Background parenchymal enhancement on contrast-enhanced spectral mammography does not represent an influencing factor for breast cancer: A preliminary study
por: Yu, Liangliang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7kh92j951ki47m6q27mkurke41